Michael Kamberov

Over the past year, Ashley has led the design and enterprise-wide deployment of Bristol Myers Squibb’s first-ever Business Process Management (BPM) capability across the global Drug Development organization (>5000+ employees). Standing up this capability involved not just process mapping and technology deployment, but deep change management and stakeholder alignment in the face of inevitable complexity. This session will offer a behind-the-scenes case study sharing lessons learned and the path forward.

·       Designing BPM from ground up: How we structured and launched our first BPM capability in a complex, global biopharma environment

·       Key lessons learned from leading change and transformation throughout the program

·       Going beyond process mining to make the best data-driven decisions linked directly to the organizational goals

·       The future roadmap of integrating AI to build the next generation capabilities

Most AI and automation programs stall not because the tech fails, but because process reality is fragmented: inconsistent execution, unclear ownership, and uncontrolled change. In this session, we’ll share a practical blueprint for building an AI-Ready Process Foundation - a decision-grade process inventory with governance, controls, and measurable KPIs - so organizations can reduce variation, accelerate improvement, and scale AI and automation responsibly. You’ll leave with a clear “what to build first” sequence and the metrics to prove progress from pilots to enterprise scale.